Randomised clinical trial: L-ornithine-L-aspartate reduces significantly the increase of venous ammonia concentration after TIPSS. (Q50643497)

17 March 2018

title

Randomised clinical trial: L-ornithine-L-aspartate reduces significantly the increase of venous ammonia concentration after TIPSS. (English)

1 reference

17 March 2018

author name string

M Bai

1

1 reference

17 March 2018

C He

2

1 reference

17 March 2018

Z Yin

3

1 reference

17 March 2018

J Niu

4

1 reference

17 March 2018

Z Wang

5

1 reference

17 March 2018

X Qi

6

1 reference

17 March 2018

L Liu

7

1 reference

17 March 2018

Z Yang

8

1 reference

17 March 2018

W Guo

9

1 reference

17 March 2018

J Tie

10

1 reference

17 March 2018

W Bai

11

1 reference

17 March 2018

J Xia

12

1 reference

17 March 2018

H Cai

13

1 reference

17 March 2018

J Wang

14

1 reference

17 March 2018

K Wu

15

1 reference

17 March 2018

D Fan

16

1 reference

17 March 2018

G Han

17

1 reference

17 March 2018

language of work or name

English

0 references

publication date

15 May 2014

1 reference

17 March 2018

Alimentary Pharmacology & Therapeutics

published in

1 reference

17 March 2018

volume

40

1 reference

17 March 2018

issue

1

1 reference

17 March 2018

page(s)

63-71

1 reference

17 March 2018

The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension

cites work

1 reference

Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension

21 January 2018

1 reference

Review article: the burden of hepatic encephalopathy

21 January 2018

1 reference

Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy.

21 January 2018

1 reference

Persistence of cognitive impairment after resolution of overt hepatic encephalopathy

21 January 2018

1 reference

Brain dysfunction primarily related to previous overt hepatic encephalopathy compared with minimal hepatic encephalopathy: resting-state functional MR imaging demonstration

21 January 2018

1 reference

Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study

21 January 2018

1 reference

Pathogenetic mechanisms of hepatic encephalopathy

21 January 2018

1 reference

Mechanisms, diagnosis and management of hepatic encephalopathy

21 January 2018

1 reference

Correlation between ammonia levels and the severity of hepatic encephalopathy.

21 January 2018

1 reference

Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors.

21 January 2018

1 reference

Current concepts in the assessment and treatment of hepatic encephalopathy

21 January 2018

1 reference

L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure

21 January 2018

1 reference

Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.

21 January 2018

1 reference

L-ornithine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action.

21 January 2018

1 reference

l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.

21 January 2018

1 reference

A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy

21 January 2018

1 reference

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

21 January 2018

1 reference

Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt

21 January 2018

1 reference

A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis

21 January 2018

1 reference

Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial

21 January 2018

1 reference

A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt.

21 January 2018

1 reference

Effect of l-ornithine l-aspartate against thioacetamide-induced hepatic damage in rats

21 January 2018

1 reference

Effect of transjugular intrahepatic portosystemic shunt placement on renal function: a 7-year, single-center experience

21 January 2018

1 reference

Advanced hemodynamic monitoring before and after transjugular intrahepatic portosystemic shunt: implications for selection of patients--a prospective study

21 January 2018

1 reference

Diagnostic methods in hepatic encephalopathy

21 January 2018

1 reference

Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Clinical, laboratory, psychometric, and electroencephalographic investigations

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12795

1 reference

17 March 2018

1 reference

17 March 2018